Price
Financials
Consolidated, Rs crore| Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 490 | 480 | 447 | 364 | 310 | 278 | 263 | 111 | 113 |
| Expenses | 459 | 403 | 392 | 265 | 262 | 227 | 211 | 93 | 120 |
| Operating Profit | 32 | 77 | 54 | 100 | 48 | 51 | 52 | 18 | -7 |
| OPM % | 7% | 16% | 12% | 27% | 16% | 18% | 20% | 16% | -6% |
| Other Income | 3 | 6 | 0 | -0 | 0 | -0 | 0 | 0 | -320 |
| Interest | 15 | 35 | 23 | 29 | 57 | 36 | 52 | 12 | 22 |
| Depreciation | 4 | 10 | 7 | 27 | 16 | 15 | 15 | 11 | 16 |
| Profit before tax | 16 | 38 | 24 | 43 | -24 | -1 | -15 | -4 | -365 |
| Tax % | 16% | -18% | 14% | -2% | -51% | 34% | -59% | 0% | -27% |
| Net Profit | 13 | 44 | 21 | 44 | -12 | -2 | -6 | -4 | -266 |
| EPS in Rs | 3.88 | 13.03 | 6.16 | 12.94 | -3.52 | -0.49 | -1.85 | -1.19 | -77.99 |
| Sep 2006 | Dec 2007 15m | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 15m | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 366 | 549 | 905 | 1,249 | 1,529 | 1,557 | 1,632 | 2,060 | 765 |
| Expenses | 272 | 410 | 774 | 1,014 | 1,191 | 1,342 | 1,470 | 1,766 | 652 |
| Operating Profit | 93 | 140 | 131 | 235 | 338 | 215 | 161 | 294 | 113 |
| OPM % | 26% | 25% | 15% | 19% | 22% | 14% | 10% | 14% | 15% |
| Other Income | 10 | 38 | 16 | 27 | -2 | 23 | 33 | 42 | -320 |
| Interest | 6 | 10 | 23 | 35 | 40 | 89 | 67 | 175 | 122 |
| Depreciation | 5 | 7 | 16 | 17 | 26 | 18 | 18 | 64 | 58 |
| Profit before tax | 92 | 161 | 109 | 210 | 269 | 131 | 109 | 97 | -386 |
| Tax % | 4% | 2% | -13% | -3% | 9% | 22% | 7% | -14% | |
| Net Profit | 89 | 158 | 123 | 217 | 244 | 103 | 101 | 111 | -278 |
| EPS in Rs | 25.81 | 46.48 | 36.21 | 63.68 | 71.74 | 30.21 | 29.79 | 32.49 | -81.52 |
| Dividend Payout % | 10% | 5% | 7% | 4% | 3% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 18% | 10% | -52% | ||
| Compounded Profit Growth | % | -10% | -23% | -56% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | 14% | 9% | 7% |
| Sep 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 34 | 34 | 34 | 34 | 34 | 34 | 34 | 34 |
| Reserves | 412 | 559 | 702 | 856 | 1,037 | 1,331 | 1,333 | 1,580 |
| Borrowings | 95 | 383 | 682 | 612 | 581 | 1,069 | 1,187 | 1,391 |
| Other Liabilities | 48 | 43 | 92 | 87 | 180 | 126 | 177 | 309 |
| Total Liabilities | 588 | 1,018 | 1,509 | 1,590 | 1,832 | 2,559 | 2,732 | 3,315 |
| Fixed Assets | 177 | 111 | 425 | 401 | 411 | 445 | 427 | 986 |
| CWIP | 24 | 2 | 191 | 213 | 255 | 401 | 395 | 0 |
| Investments | 43 | 409 | 199 | 199 | 199 | 199 | 199 | 199 |
| Other Assets | 344 | 496 | 694 | 776 | 967 | 1,514 | 1,711 | 2,130 |
| Total Assets | 588 | 1,018 | 1,509 | 1,590 | 1,832 | 2,559 | 2,732 | 3,315 |
| Sep 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -39 | 70 | 138 | 165 | 176 | -272 | -61 | 244 |
| Cash from Investing Activity | -39 | -255 | -409 | -14 | -101 | -15 | 23 | -490 |
| Cash from Financing Activity | 146 | 266 | 167 | -147 | -85 | 357 | -40 | 249 |
| Net Cash Flow | 68 | 81 | -105 | 4 | -10 | 70 | -79 | 2 |
| Free Cash Flow | -65 | 67 | -248 | 152 | 91 | -373 | -56 | -386 |
| CFO/OP | -36% | 50% | 115% | 64% | 55% | -118% | -43% | 78% |
| Sep 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 232 | 177 | 157 | 133 | 152 | 228 | 274 | 198 |
| Inventory Days | 42 | 17 | 114 | 84 | 73 | 76 | 72 | 60 |
| Days Payable | 25 | 16 | 66 | 35 | 62 | 23 | 24 | 32 |
| Cash Conversion Cycle | 249 | 177 | 205 | 181 | 163 | 281 | 322 | 225 |
| Working Capital Days | 234 | 204 | 212 | 177 | 171 | 300 | 337 | 281 |
| ROCE % | 20% | 17% | 17% | 20% | 14% | 7% | 10% |
| Jun 2016 | |
|---|---|
| Promoters | 57.75% |
| FIIs | 2.70% |
| DIIs | 16.71% |
| Public | 22.84% |
| No. of Shareholders | 16,430 |
Fundamentals
Market Cap₹ 30.8 Cr.
Current Price₹ 7.94
Stock P/E0.74
Book Value₹ 415
ROCE9.77 %
ROE7.43 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-52%
Compounded Profit Growth (TTM)-56%
Consolidated figures.
Valuation
P/E, 3-year average7.56x
P/B, 3-year average1.16x
P/E, 5-year average7.18x
P/B, 5-year average1.33x
Profitability
Operating margin (excl. other income)13.80%
Operating margin (incl. other income)15.26%
EBITDA margin17.59%
Pre-tax margin-4.67%
Net profit margin-2.50%
Net margin, latest quarter-3.65%
ROE8.45%
ROCE10.77%
ROA4.69%
ROE, 3-year average20.02%
ROCE, 3-year average15.72%
ROA, 3-year average10.99%
ROE, 5-year average21.82%
ROCE, 5-year average16.16%
ROA, 5-year average12.49%
ROIC (approx.)3.78%
Tax rate21.56%
Other income / net worth1.66%
Growth
Sales growth (latest year)1.86%
Profit growth (latest year)-57.89%
Sales CAGR, 3 years19.82%
Sales CAGR, 5 years33.60%
Profit CAGR, 3 years-5.86%
Profit CAGR, 5 years3.20%
Sales growth QoQ-57.62%
Sales growth YoY (latest quarter)-69.41%
Profit growth YoY (latest quarter)-109.24%
Per share
EPS (TTM)Rs -7.06
EPS (latest year)Rs 30.21
EPS (latest quarter)Rs -1.19
EPS, 3-year averageRs 55.21
EPS, 5-year averageRs 49.66
Book value per shareRs 400.64
Sales per shareRs 282.54
Cash flow per shareRs -79.75
Free cash flow per shareRs -113.31
Dividend per share, 3-year averageRs 2.50
Dividend per share, 5-year averageRs 2.50
Dividends
Dividend payout, 3-year average3.71%
Dividend payout, 5-year average4.93%
Efficiency
Asset turnover0.61x
Fixed asset turnover3.50x
Inventory turnover5.13x
Inventory days71 days
Debtor days228 days
Debtors turnover1.60x
Creditor days32 days
Cash conversion cycle225 days
Working capital days281 days
Leverage
Total debtRs 1,069 Cr
Cash and bankRs 110 Cr
Net debtRs 958 Cr
Debt to equity0.78x
Net debt / EBITDA5.66x
Interest coverage0.71x
Owners' fund to total sources53.33%
Debt to assets41.75%
Cash flow
Cash from Operating Activity (latest year)Rs -272 Cr
Cash from Investing Activity (latest year)Rs -15 Cr
Cash from Financing Activity (latest year)Rs 357 Cr
Net Cash Flow (latest year)Rs 70 Cr
Free cash flow (latest year)Rs -386 Cr
FCFE (approx.: FCF + change in debt)Rs 102 Cr
Cash from ops / profit, 5 years0.19x
Statement figures
Net sales (TTM)Rs 963 Cr
Net sales (latest year)Rs 1,557 Cr
Sales (latest quarter)Rs 111 Cr
Operating profit excl. other income (latest year)Rs 215 Cr
Operating profit (latest quarter)Rs 18 Cr
Other income (TTM)Rs 23 Cr
EBITDA (TTM)Rs 169 Cr
PBDT (TTM)Rs 12 Cr
Profit before tax (TTM)Rs -45 Cr
Tax (latest year)Rs 28 Cr
Net profit (TTM)Rs -24 Cr
Net profit (latest year)Rs 103 Cr
Net profit (latest quarter)Rs -4 Cr
Depreciation (TTM)Rs 57 Cr
Depreciation (latest quarter)Rs 11 Cr
Interest (TTM)Rs 157 Cr
Cost of goods sold (latest year)Rs 934 Cr
Total expenditure (latest year)Rs 1,342 Cr
Total income (latest year)Rs 1,580 Cr
Share capitalRs 34 Cr
ReservesRs 1,331 Cr
Shareholders' fundsRs 1,365 Cr
Total assetsRs 2,559 Cr
Net blockRs 445 Cr
Capital work in progressRs 401 Cr
InvestmentsRs 199 Cr
ReceivablesRs 971 Cr
InventoryRs 182 Cr
Other liabilitiesRs 126 Cr
Shares outstanding (crore)3.41
Ownership
Promoter holding57.75%
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 2 of 8| explain | Weak cash conversion Cash from operations was 12% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 15% of total assets in 2014 |
| explain | Receivables outrunning sales Receivables grew 52% vs sales +2% in 2014 |
| explain | Debt up, profit down Borrowings up 84% while net profit fell in 2014 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2015Sales ₹113 Cr -63.5% vs Mar 2014.
Net loss ₹266 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Plethico Pharmaceuticals Ltd?
Plethico Pharmaceuticals Ltd (532739) has a market capitalisation of Rs 30.8 Cr. at the close.
What is the P/E ratio of Plethico Pharmaceuticals Ltd?
Plethico Pharmaceuticals Ltd trades at a P/E of 0.74 on trailing twelve-month profit, at the close.
What were Plethico Pharmaceuticals Ltd's latest quarterly results?
In the Mar 2015 quarter, Plethico Pharmaceuticals Ltd sales was Rs 113 Cr (-63.5% vs Mar 2014) with a net loss of Rs 266 Cr.